2003

Oct 2, 2003
Guidant Appoints Beverly H. Lorell, M.D., Vice President, Chief Medical and Technology Officer

New Position Will Lead Technology Development Strategy INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Beverly...

Sep 23, 2003
COMPANION Trial Results to be Announced During Late Breaking Scientific Session at the Heart Failure Society of America 7th Annual Scientific Meeting

Updated Landmark Heart Failure Trial Data Submitted to Peer-Reviewed Journal LAS VEGAS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Sep 23, 2003
Guidant Completes Enrollment in Clinical Investigation of New Therapy for Stroke Prevention

Second Clinical Trial Advances Efforts to Develop Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world...

Sep 19, 2003
Guidant's Institute for Therapy Advancement Europe Welcomes 5,000th Participant

Institute Demonstrates Guidant''s Leadership in Medical Education Brussels, Belgium - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Sep 18, 2003
David E. Kandzari, M.D., Wins First Annual Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award

Guidant-Supported Grant Honors Late Chief Medical Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...

Sep 18, 2003
Guidant Announces Additional Findings of Key Study In Emerging Field of Heart Attack Prevention

Vulnerable Plaque Study Shows Correlation Between Lipid-Rich Plaques and Heart Attacks in Cath Lab Patients Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...

Sep 17, 2003
Guidant Reports Positive Results of Two Everolimus Eluting Coronary Stent Clinical Trials

FUTURE I and II Trials Utilize Everolimus with Bioabsorbable Polymer; Results Presented Today Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Sep 11, 2003
Guidant to Host Investor Briefing at Transcatheter Cardiovascular Therapeutics Meeting

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will host an investor briefing...

Sep 4, 2003
Guidant to Participate in Bear Stearns 16th Annual Healthcare Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...

Sep 2, 2003
Guidant Acquires Innovative Polymer Technology for Drug Eluting Stent Program

"Programmable" Polymer Capabilities Strengthen Guidant''s Development of Future Therapies for Coronary Artery Disease Indianapolis and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a...

Show 5102550100 per page
Top